This video is featured in the 2024 ASH Annual Meeting Insights Hub

2024 ASH Annual Meeting Insights Hub
T

ASH 2024 Insights: Ven + HMA vs. HMA Alone in TP53m HR-MDS - Real-World Mayo Clinic Series

By 2024 ASH Annual Meeting Insights Hub FEATURING Talha Badar
By 2024 ASH Annual Meeting Insights Hub FEATURING Talha Badar
8 views
December 24, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

2024 ASH Annual Meeting Insights Hub: MDS & MPN Videos

04:51

New

ASH 2024 Summary: Survival Outcomes in Patients With MF & New or Wor…

2024 ASH Annual Meeting Insights Hub

A. Kuykendall

8 views
25:03

New

ASH 2024 Summary: Highlights in AML, MDS, and ALL

2024 ASH Annual Meeting Insights Hub

T. Badar

140 views
15:16

New

ASH 2024 Summary: Transplant Options and Outcomes for TP53 Myeloid D…

2024 ASH Annual Meeting Insights Hub

H. Fernandez

83 views
View All

Related Videos

Total Health

West Oncology Conference

Sat, Feb 8, 2025
21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

3.6K views
27:49

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Insights from 2024 EHA Annual Meeting

T. Badar

740 views
25:44

Myeloid Malignancies: Hot Topics in 2024

Yale Cancer Center

N. Podoltsev

281 views
14:32

Summary of Recent Updates in MDS

Vanderbilt University Medical Center (VUMC)

S. Ball

445 views
22:37

AML and MDS Highlights & Key Takeaways

Insights from 2023 ASH Annual Meeting

T. Badar

2.2K views
23:04

Differentiation of CHIP, ICUS, CCUS, MDS, and VEXAS Syndrome

MyCancerHaven

R. Vij, S. Abedin

257 views
31:53

HSCT in 2024: What Every Hematologist Needs to Know

Indy Hematology Review

R. Childs

761 views
24:44

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

916 views
04:16

MDS and AML: Implementation of Guideline-Driven Germline Genetic Eva…

UChicago Medicine 12th International Clinical Cancer Genomics Conference

L. Banaszak

406 views
20:58

New

Defining Risk of Progression in CHIP/CCUS: A Pathologists' Perspecti…

16th International Congress on Myeloproliferative Neoplasms

R. Hasserjian

94 views
23:37

Management of Viral Infections Post-Transplant: CMV, EBV, and HHV-6

Rush University Medical Center

E. Bhaimia

345 views
18:44

Current and Emerging Treatment Approaches for Patients With AML or M…

University of Miami Sylvester Comprehensive Cancer Center

S. Venugopal

138 views
13:26

Chronic GvHD: Main Complications After ASCT

Steven Pavletic

370 views
15:16

New

ASH 2024 Summary: Transplant Options and Outcomes for TP53 Myeloid D…

2024 ASH Annual Meeting Insights Hub

H. Fernandez

83 views
09:42

ASCO® 2024 Insights: "Post-Transplant Cyclophosphamide-Based GvHD Pr…

2024 ASCO® Annual Meeting Insights Hub

M. Al Malki

274 views
25:38

Allo-HSCT Conditioning Regimens: Current Status and Future Directions

Rush University Medical Center

C. Brunstein

266 views
25:12

Bone Marrow Failure: The Importance of Mutational Testing

Rush University Medical Center

J. Shammo

261 views
16:55

Making Sense of the New Classification Systems for MDS in 2024

Moffitt Cancer Center

R. Komrokji

444 views
12:15

Using Transplant in Patients With p53 Mutant MDS or AML

Moffitt Cancer Center

H. Elmariah

334 views
17:01

Are We Closer to Conquering HR-MDS?

SOHO Brazil 2024

R. Komrokji

104 views
AUTOPLAY